Tagged: VRX

science lab 0

Inorganic Growth Becoming Norm For US Pharma As Endo International Loses Salix Pharmaceuticals, Ltd. (SLXP) To Valeant Pharmaceuticals Intl Inc (VRX) In A $15.8 Billion Deal

The pharmaceutical industry has found a new way to grow and overcome challenges, but the approach raises questions about the future of health care. For the likes of Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and Pfizer...

Valeant VRX 0

Charlie Munger’s Comments on Valeant Pharmaceuticals Intl Inc (VRX) — ITT and Harold Geneen

Valeant Pharmaceuticals Intl Inc (NYSE:VRX)(TSE:VRX) has been a hot topic for investors as the company has witnessed a meteoric rise from just over $13 when J. Michael Pearson became CEO in February 2008, to $201.38...

Endo Logo 0

Why Valeant Pharmaceuticals Intl Inc May Win In Battle For Salix Pharmaceuticals, Ltd. Over Endo International PLC

Valeant Pharmaceuticals Intl Inc (NYSE:VRX) is expected to emerge as the eventual winner of the war-of-bids, considering that it is consistent with the price. Endo International plc – Ordinary Shares (NASDAQ:ENDP) desperate offer to own Salix Pharmaceuticals,...

Endo Logo 0

Endo International plc (ENDP) Enters $10 Billion Offer for Salix Pharmaceuticals, Ltd. Putting Pressure On Valeant Pharmaceuticals Intl Inc

Endo International plc – Ordinary Shares (NASDAQ:ENDP) adds competition for Valeant Pharmaceuticals Intl Inc (NYSE:VRX) for Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) by placing an enticing counter-offer. Endo has, in a purported private letter, addressed to the Salix Pharmaceutical board proposed...

Valeant VRX 0

Valeant Pharmaceuticals Intl Inc (VRX) Acquisition Of Salix Pharmaceuticals, Ltd. (SLXP) To Create New Specialty Platform

Valeant Pharmaceuticals Intl Inc (NYSE:VRX)’s decision to acquire Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) would establish a new specialty platform for growth opportunities. Valeant believes that Salix’s market-leading gastrointestinal franchise was a perfect tactical fit for...